Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Perrigo Ships Guaifenesin/PSE Tablets, But Single-Ingredient Snags Linger

This article was originally published in The Tan Sheet

Executive Summary

Perrigo launches store brand Mucinex D, containing guaifenesin and PSE, manufactured by Allergan, but also suspends marketing its own guaifenesin product due to problems with an excipient used in the formula.

Advertisement

Related Content

Mutual Alleges Mucinex Monopoly In Extended-Release Guaifenesin
Perrigo’s Mucinex Equivalent On The Cusp, But New Product Outlook Dims
Perrigo Sets Generic Mucinex Launch After Patent Claim Decision

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register